Condition: Usher Syndromes · Sponsor: Centre Hospitalier National d'Ophtalmologie des Quinze-Vingts
Clinical centres in the LIGHT4DEAF consortium have developed and will continue to improve a reliable, early molecular diagnosis and protocols for full clinical characterisation of Usher syndrome, which will be valuable for the foreseen USH clinical trials. The clinical arm of the project aims at performing a deep-phenotyping of retinal degeneration, hearing loss, vestibular dysfunction, neurocognitive ability of subects with a molecular diagnosis of any Usher syndrome. Functional and structural parameters for retinal, auditory, and vestibular impairments are followed overtime to document the natural history of the disease and establish relevant clinical endpoint for disease progression that may be useful for future clinical trials.
This description comes directly from the study's public registry record.
Isabelle AUDO, Pr · 0140021430 · isabelle.audo@inserm.fr
Thilissa DIB · 0140021455 · tdib@15-20.fr
Always discuss trial participation with your own doctor first.
| Centre Hospitalier National d'Ophtalmologie des Quinze-Vingts | Paris, France | Recruiting |
| CHU Pitié Salpêtrière | Paris, France | Recruiting |
| CHU Necker | Paris, France | Recruiting |
| CHU Robert Debré | Paris, France | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04665726